Subsequently, a growing number of studies have found that FEZF1-AS1 is up-regulated in PC, ovarian cancer, NPC, HCC, CRC, MM, BC, OS, NSCLC, GC and other malignancies. This evidence concerns the gene FEZF1 and ovarian cancer.